Markets:

Overview

News

Currencies

International

Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

53.46 +0.69 (+1.31%)

Streaming Delayed Price Updated: 3:40 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Roche Holding AG Basel American Depositary Shares

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Amneal's Avastin-Referred Biosimilar Under FDA Review For Colorectal Cancer ↗

June 17, 2021

The FDA has accepted for review Amneal Pharmaceuticals Inc's (NYSE: AMRX) marketing application seeking approval for Bevacizumab, under Section 351(k) pathway...

Via Benzinga

Synlogic, Roche Ink Research Pact For Inflammatory Bowel Disease Therapy ↗

June 17, 2021

Synlogic Inc (NASDAQ: SYBX) has entered into a research collaboration agreement with Roche Holding AG (OTC: RHHBY) for the discovery of Synthetic Biotic...

Via Benzinga

Atea Pharma Secures AT-527-Related Milestone Payment Of $50M From Roche ↗

June 16, 2021

Atea Pharmaceuticals Inc (NASDAQ: AVIR) has achieved a development milestone associated with AT-527 and expects to receive a related payment under its license...

Via Benzinga

Continued Uncertainty ↗

June 15, 2021

Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all.

Via Talk Markets

Stock Profile: Roche Holding AG ADR ↗

June 12, 2021

Roche maintains a healthy balance sheet with $13.9 billion in cash and investments and $12.5 billion in long-term debt as of 12/31/2020.

Via Talk Markets

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Dreary Day ↗

June 14, 2021

Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.

Via Talk Markets

JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia Patients ↗

June 14, 2021

A combination of Johnson & Johnson’s (NYSE: JNJ) Imbruvica and AbbVie Inc (NYSE: ABBV) - Roche Holding AG’s (OTC: RHHBY) Venclexta/...

Via Benzinga

Happy Friday ↗

June 11, 2021

The inflation risk is being ignored by the US market now that there will probably not be a tax increase and may be higher prices for longer.

Via Talk Markets

AbbVie-Roche's Venclexta Shows Progression-Free Survival Of 74% In CLL Patients After Three Years Treatment ↗

June 11, 2021

Genentech, a unit of Roche Holdings AG (OTC: RHHBY), and its collaborating partner AbbVie Inc (NYSE: ABBV) have announced long-term follow-up data ...

Via Benzinga

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

Genentech Announces Data at EHA2021 Reinforcing Efficacy of Venclexta Combinations in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia

June 11, 2021

From Genentech

Via Business Wire

New Genentech Data for Evrysdi (risdiplam) Show Improved Motor Function in Pre-Symptomatic Babies After One Year and Confirm Safety Profile in Previously Treated People With Spinal Muscular Atrophy (SMA)

June 11, 2021

From Genentech

Via Business Wire

Unheeding Markets ↗

June 10, 2021

Today oil prices rose over $70.

Via Talk Markets

With Aduhelm Approval Behind Biogen, 5 Catalysts For Investors To Watch ↗

June 10, 2021

Biogen Inc. (NASDAQ: BIIB) made history of sorts with the FDA approval for its Alzheimer's treatment Aduhelm. Notwithstanding the still-raging debate over the decision, an...

Via Benzinga

Wednesday News And Catch-Up ↗

June 09, 2021

Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.

Via Talk Markets

Topics Stocks

Juvenile Investing Mob ↗

June 08, 2021

Tech stocks did well in Europe but not in the US. The data are unconvincing.

Via Talk Markets

The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex ↗

June 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc...

Via Benzinga

FDA surprise ↗

June 07, 2021

The big news out of China is that its import purchases of copper and iron sagged last month because its export markets are far less strong than earlier this year.

Via Talk Markets

Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab ↗

June 07, 2021

The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.

Via Investor's Business Daily

Argenx Regains Global Rights from Johnson & Johnson to Blood Cancer Candidate Cusatuzumab ↗

June 07, 2021

Johnson & Johnson (NYSE: JNJ) has walked away from a $1.6 billion blood cancer candidate deal with Argenx SE (NASDAQ: ARGX) for the CD70-targeting...

Via Benzinga

A Better Switch ↗

June 04, 2021

Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase.

Via Talk Markets

Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer ↗

June 04, 2021

Surface Oncology (NASDAQ: SURF) has entered into a clinical trial collaboration with Roche Holdings AG (OTC: RHHBY) to evaluate former's SRF388, anti...

Via Benzinga

Genentech Presents Latest Advances With Immunotherapies in Non-Hodgkin’s Lymphoma

June 04, 2021

From Genentech

Via Business Wire

Fan Hit ↗

June 03, 2021

The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.

Via Talk Markets

Constellation Pharma Rockets On Word Of $1.7 Billion MorphoSys Takeover ↗

June 02, 2021

MorphoSys announced its $1.7 billion plan to acquire cancer treatment biotech Constellation on Wednesday and CNST stock rocketed to a four-month high.

Via Investor's Business Daily

Biogen, Bio-Thera's Biosimilar Referencing Tocilizumab Meets Primary Endpoints In Late-Stage Study ↗

June 01, 2021

Biogen Inc (NASDAQ: BIIB) and China's Bio-Thera Solutions Ltd have announced results from the Phase 3 study of BAT1806, a proposed biosimilar referencing...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

Sterling At Five-Year High ↗

May 25, 2021

Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.

Via Talk Markets

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.